NCT06682780
- Conditions
- Advanced Solid Tumor
- Locations
-
- FuDan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China
Clinical trial condition
Advanced Solid Tumor
Explore clinical trials studying Advanced Solid Tumor. Study availability and eligibility vary by location and protocol.
524 public trials
244 recruiting studies
Advanced Solid Tumor trial results
NCT07793500
- Conditions
- Adenoviridae Infections, Advanced Solid Tumor, Bronchial Neoplasms, +13 more
- Locations
-
- No.17 Panjiayuan Nanli, Chaoyang District, Beijing Beijing, China
NCT05038150
- Conditions
- Advanced Solid Tumor
- Locations
-
- Banner MD Anderson Cancer Center Gilbert, Arizona, United States
- Health Chao Family Comprehensive Cancer Center Orange, California, United States
- Barbara Ann Karmanos Cancer Hospital dba Karmanos Cancer Center Detroit, Michigan, United States
- University of Cincinnati Cancer Center Cincinnati, Ohio, United States
Recruiting
Study of SGN1 Administered Via Intratumoral Injection in Patients With Advanced Solid Tumor
NCT05103345
- Conditions
- Advanced Solid Tumor
- Locations
-
- Guangdong Clifford Hospital Guangzhou, Guangdong, China
- West China Hospital of Sichuan University Chengdu, Sichuan, China
- Taipei Medical University-Shuang Ho Hospital,Ministry of Health and Welfare New Taipei City, Taiwan
- China Medical University Hospital Taichung, Taiwan
Recruiting
ARC101 in Advanced Solid Tumors
NCT06672185
- Conditions
- Advanced Solid Tumor
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
- START Midwest Grand Rapids, Michigan, United States
- START San Antonio, LLC. San Antonio, Texas, United States
- Sunshine Coast University Private Hospital Birtinya, Queensland, Australia
NCT07681882
- Conditions
- Advanced Solid Tumor, Metastatic Solid Tumor, Neoplasm Metastasis, +5 more
- Locations
-
- Kansai Medical University Hospital Osaka, Japan
- The Cancer Institute Hospital of JFCR Tokyo, Japan
- National Cancer Center Hospital East Kashiwa, Japan
NCT05901285
- Conditions
- Advanced Solid Tumor, Advanced Solid Tumors Appropriate for Treatment With Either Nivolumab or Pembrolizumab
- Locations
-
- University of Arizona Cancer Center Tucson, Arizona, United States
- Sarah Cannon Research Institute at HealthONE Denver, Colorado, United States
- George Washington University Washington D.C., District of Columbia, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States
NCT06803680
- Conditions
- Advanced Solid Tumor, Metastatic Solid Tumor, Neoplasm Metastasis, +4 more
- Locations
-
- Adventhealth Celebration, Florida, United States
- Sidney Kimmel Cancer Center Philadelphia, Pennsylvania, United States
- Avera Cancer Institute Sioux Falls, South Dakota, United States
- Next Oncology San Antonio, Texas, United States
NCT05765851
- Conditions
- Advanced Solid Tumor
- Locations
-
- Florida Cancer Specialists Sarasota, Florida, United States
- Lifespan Cancer Institute Providence, Rhode Island, United States
- University of Utah Salt Lake City, Utah, United States
- NEXT Oncology Fairfax, Virginia, United States
Recruiting
FIH XON7 in Advanced/Metastatic Solid Tumors
NCT06154291
- Conditions
- Advanced Solid Tumor, Metastatic Cancer, Neoplasm Metastasis, +4 more
- Locations
-
- Institut Jules Bordet Anderlecht, Belgium
- Institut Bergonié Bordeaux, France
- Centre Léon Bérard Lyon, France
- Hôpital Foch Suresnes, France